{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:46:11Z","timestamp":1782337571899,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007707","name":"University of California Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.wneu.2026.125041","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:38:35Z","timestamp":1778283515000},"page":"125041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metastatic Meningioma with Systemic Involvement: Discussion of Molecular, Genomic, and Radiological Features"],"prefix":"10.1016","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7823-6876","authenticated-orcid":false,"given":"Muhammad","family":"Sulman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8708-2302","authenticated-orcid":false,"given":"Alexander","family":"Del Bosque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1580-5829","authenticated-orcid":false,"given":"Diego","family":"Cantillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9363-5704","authenticated-orcid":false,"given":"John Paul","family":"Aboubechara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vihar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9204-6759","authenticated-orcid":false,"given":"Kiarash","family":"Shahlaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3255-5492","authenticated-orcid":false,"given":"Lotfi","family":"Hacein-Bey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7916-1629","authenticated-orcid":false,"given":"Orwa","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2026.125041_bib1","first-page":"73","article-title":"Meningioma and other meningeal tumors","volume":"2","author":"Bailo","year":"2023"},{"key":"10.1016\/j.wneu.2026.125041_bib2","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","article-title":"Meningioma: International consortium on meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients","volume":"26","author":"Wang","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2026.125041_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1137849","article-title":"Intracranial meningiomas: an update of the 2021 World Health Organization classifications and review of management with a focus on radiation therapy","volume":"13","author":"Yarabarla","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2026.125041_bib4","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00701-023-05687-3","article-title":"Metastatic meningioma: a case series and systematic review","volume":"165","author":"Himi\u010d","year":"2023","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2026.125041_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-024-04659-6","article-title":"A systematic review of extraneural meningioma metastasis: timing, evolution and outlook","volume":"168","author":"Watanabe","year":"2024","journal-title":"J Neurooncol"},{"key":"10.1016\/j.wneu.2026.125041_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3171\/2019.1.JNS181771","article-title":"Meningioma metastases: incidence and proposed screening paradigm","volume":"132","author":"Dalle Ore","year":"2020","journal-title":"J Neurosurg"},{"key":"10.1016\/j.wneu.2026.125041_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11060-013-1074-x","article-title":"Distant metastases in meningioma: an underestimated problem","volume":"112","author":"Surov","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.wneu.2026.125041_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/14737175.2018.1429920","article-title":"Current treatment options for meningioma","volume":"18","author":"Apra","year":"2018","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.wneu.2026.125041_bib9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00701-021-05101-w","article-title":"Genetic analysis of a malignant meningioma and associated metastases","volume":"164","author":"Huntoon","year":"2022","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2026.125041_bib10","article-title":"Case report: recurrent meningioma with multiple metastases","volume":"13","author":"Zhou","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2026.125041_bib11","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1016\/j.wneu.2024.09.013","article-title":"Metastasis of World Health Organization grade II and grade III meningiomas: long-term survival and associated factor analysis","volume":"191","author":"Wang","year":"2024","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2026.125041_bib12","doi-asserted-by":"crossref","first-page":"E461","DOI":"10.1093\/neuros\/nyy610","article-title":"Malignant meningioma: an international multicentre retrospective study","volume":"85","author":"Champeaux","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2026.125041_bib13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2026.125041_bib14","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/neuonc\/noac032","article-title":"The impact of brain invasion criteria on the incidence and distribution of WHO grade 1, 2, and 3 meningiomas","volume":"24","author":"Rebchuk","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2026.125041_bib15","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1016\/j.wneu.2024.04.082","article-title":"Prognostic factors and outcomes in World Health Organization grade 1 and grade 2 intracranial Meningiomas\u20145-Year institutional experience","volume":"187","author":"Nadeem","year":"2024","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2026.125041_bib16","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2026.125041_bib17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of Non- NF2 meningiomas reveals mutations in TRAF7 , KLF4 , AKT1 , and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.wneu.2026.125041_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv377","article-title":"TERT promoter mutations and risk of recurrence in meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.wneu.2026.125041_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11060-018-2756-1","article-title":"Pediatric versus adult meningioma: comparison of epidemiology, treatments, and outcomes using the surveillance, epidemiology, and end results database","volume":"137","author":"Dudley","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.wneu.2026.125041_bib20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00381-019-04156-6","article-title":"Management of pediatric CNS meningiomas: CCHE-57357 experience in 39 cases","volume":"35","author":"El Beltagy","year":"2019","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.wneu.2026.125041_bib21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jocn.2010.11.036","article-title":"A clinicopathological and neuroradiological study of paediatric meningioma from a single centre","volume":"18","author":"Jaiswal","year":"2011","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.wneu.2026.125041_bib22","first-page":"535","article-title":"Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas","volume":"19","author":"Shankar","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2026.125041_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3174\/ajnr.A8368","article-title":"Meningioma: molecular updates from the 2021 World Health Organization classification of CNS tumors and imaging correlates","volume":"46","author":"Soni","year":"2025","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.wneu.2026.125041_bib24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoncol.2024.5506","article-title":"Molecular testing for the World Health Organization Classification of central nervous system tumors: a review","volume":"11","author":"Horbinski","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.wneu.2026.125041_bib25","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.wneu.2026.125041_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","article-title":"CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas","volume":"140","author":"Sievers","year":"2020","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.wneu.2026.125041_bib27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1200\/JCO.21.02371","article-title":"Alliance A071401: phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations","volume":"41","author":"Brastianos","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.wneu.2026.125041_bib28","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014960","article-title":"mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition","volume":"296","author":"Beauchamp","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.wneu.2026.125041_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-022-04148-8","article-title":"Emerging systemic treatment options in meningioma","volume":"161","author":"Mair","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.wneu.2026.125041_bib30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/CCO.0000000000000687","article-title":"Molecular alterations in meningioma: prognostic and therapeutic perspectives","volume":"32","author":"Birzu","year":"2020","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.wneu.2026.125041_bib31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/WCO.0000000000001002","article-title":"Chemotherapy and targeted therapies for meningiomas: what is the evidence?","volume":"34","author":"Graillon","year":"2021","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.wneu.2026.125041_bib32","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/neuonc\/noy104","article-title":"TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma","volume":"20","author":"Spiegl-Kreinecker","year":"2018","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.wneu.2026.125041_bib33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10143-019-01087-3","article-title":"Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas \u2013 a systematic review","volume":"43","author":"St\u00f6gbauer","year":"2020","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.wneu.2026.125041_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/1078-0432.CCR-22-2085","article-title":"Pharmacological landscape of FDA-approved anticancer drugs reveals sensitivities to ixabepilone, romidepsin, omacetaxine, and carfilzomib in aggressive meningiomas","volume":"29","author":"Jungwirth","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2026.125041_bib35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/neuonc\/noac206","article-title":"Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas","volume":"25","author":"Youngblood","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2026.125041_bib36","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.3390\/cancers14092256","article-title":"Clinical significance of molecular alterations and systemic therapy for meningiomas: where do we stand?","volume":"14","author":"Pellerino","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.wneu.2026.125041_bib37","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/14737175.2023.2254498","article-title":"Advances in the systemic therapy for recurrent meningiomas and the challenges ahead","volume":"23","author":"Li","year":"2023","journal-title":"Expert Rev Neurother"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875026002573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875026002573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:47:39Z","timestamp":1782334059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875026002573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S1878875026002573"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2026.125041","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metastatic Meningioma with Systemic Involvement: Discussion of Molecular, Genomic, and Radiological Features","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2026.125041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"125041"}}